EUVIMEDEUVIMED entdecken
Crossref

Male patients with primary Sjögren’s syndrome have unique clinical manifestations and circulating lymphocyte profiles

Huan Liu, Jiangshui Yuan, Xueying Tan, Weiqing Song, Shuguo Wang

Clinical Rheumatology · 2024

DOI: 10.1007/s10067-024-06955-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Huan Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Municipal Hospital, Qingdao University, Qingdao, 266000, China. Hauptthemen laut MEDLINE: Sjogren's Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: the National Nature Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: We aimed to explore the relationship between clinical characteristics and circulating lymphocyte profiles in Chinese male patients with primary Sjögren's syndrome (pSS). METHOD: Data from 397 patients with pSS were analyzed retrospectively. 37 were male, which is a prevalence of 9.3%. The clinical, laboratory, and immunophenotypic profiles of peripheral blood lymphocyte subsets were compared between male and female pSS patients. RESULTS: Male patients with primary Sjögren's syndrome have unique clinical manifestations and circulating lymphocyte profiles. Male patients complained more about xerophthalmia and presented with more extra-glandular manifestations as compared with female patients. The CD4+/CD8+ ratio (P = 0.030), the prevalence of CD4-CD8- T cells in lymphocytes (P = 0.020), the absolute number of CD4-CD8- T cells (P = 0.035), the prevalence of CD4+ T cells in lymphocytes (P < 0.001), and the absolute number of CD4+ T cells (P = 0.023) were significantly lower in male patients compared to female patients. On the other hand, the prevalence of CD8+CD28+ T cells (P = 0.030) and CD4+CD25high T cells (P = 0.040) in lymphocytes was significantly higher in male patients than in female patients. Moreover, compared to females with pSS, an elevated serum IgG level, low C3 and C4 levels, anti-SSB positivity, and ANA titers of ≥ 1:160 positivity were more frequent in male with pSS. CONCLUSIONS: Male patients with pSS have distinctive peripheral blood lymphocyte subpopulations, present with more severe clinical symptoms and immunological features, and have an unfavorable prognosis. Key Points • Male patients with pSS have more severe clinical symptoms and specific characteristics of peripheral blood lymphocyte subsets. • Male pSS patients exhibit a higher intensity of the disease (as evaluated by ESSDAI). • Male patients with pSS require individualized treatment regimens and closer follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeHumansMaleMiddle AgedFemaleRetrospective StudiesAdultSex FactorsAgedCD4-CD8 RatioLymphocyte Subsets

Stichwörter der Autor:innen

Clinical characteristicsLymphocyte profileMalePrimary Sjögren's syndrome

Autor:innen und Institutionen

  • Qingdao Municipal Hospital, Qingdao University, Qingdao, 266000, China.
  • Department of Laboratory Medicine, Qingdao Municipal Hospital, No.5 Donghai Middle Road, Qingdao, 266000, Shandong, China.
  • Department of Laboratory Medicine, Qingdao Municipal Hospital, No.5 Donghai Middle Road, Qingdao, 266000, Shandong, China. shuguo_wang@163.com.

Förderung

  • the National Nature Science Foundation of China

Zitieren

APA

Liu, H., Yuan, J., Tan, X., Song, W., & Wang, S. (2024). Male patients with primary Sjögren’s syndrome have unique clinical manifestations and circulating lymphocyte profiles. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-06955-y

Vancouver

Liu H, Yuan J, Tan X, Song W, Wang S. Male patients with primary Sjögren’s syndrome have unique clinical manifestations and circulating lymphocyte profiles. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-06955-y

BibTeX
@article{Liu2024,
  author = {Liu, Huan and Yuan, Jiangshui and Tan, Xueying and Song, Weiqing and Wang, Shuguo},
  title = {Male patients with primary Sjögren’s syndrome have unique clinical manifestations and circulating lymphocyte profiles},
  journal = {Clinical Rheumatology},
  year = {2024},
  doi = {10.1007/s10067-024-06955-y}
}
Kostenlos starten →